Effexor - side effects

[Guest guest]

Hello all,

We added effexor on Sunday and are on day 5. The last three days, 's pretty

much had no appetite. Refusing lunch and eating very little dinner. He's never

displayed any side effects before - just wondering how long it might take to

resolve.

Thanks!

Alaine

[Guest guest]

Elaine, one of the most common side effects of taking any anti-depressant

is lack of appetite. I can tell you even adults suffer from this side

effect. In a child's case the doctor who prescribed the medication can always

prescribe certain medications to open up his appetite due to this side

effect of taking Effexor. Is he taking regular Effexor or the CR which is the

slow release form of this medicaiton. Effexor is a very good medication in the

treamtment of depression. Very expensive, but an extremely good

medication. It also treats both imbalances at the same time for depression:

your

dopamine and seratonin levels.

**************Dell Deals: Treat yourself to a sweet deal on popular

laptops!

(http://pr.atwola.com/promoclk/100126575x1223100673x1201716527/aol?redir=http:%2\

F%2Faltfarm.mediaplex.com%2Fad%2Fck%2F12309%2D81939%2D1629%2D7)

[Guest guest]

You might want to research the effect of Effexor on young children directly

from the FDA website:

FDA STATEMENT

FOR IMMEDIATE RELEASE

September 16, 2004

Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

FDA Statement on Recommendations of the Psychopharmacologic Drugs and

Pediatric Advisory Committees

The Food and Drug Administration (FDA) generally supports the

recommendations that were recently made to the agency by the

Psychopharmacologic Drugs

and Pediatric Advisory Committees regarding reports of an increased risk of

suicidality (suicidal thoughts and actions) associated with the use of

certain antidepressants in pediatric patients. FDA has begun working

expeditiously to adopt new labeling to enhance the warnings associated with the

use

of antidepressants and to bolster the information provided to patients when

these drugs are dispensed.

In summary, the members of the advisory committees:

* endorsed FDA's approach to classifying and analyzing the suicidal

events and behaviors observed in controlled clinical trials and expressed

their view that the new analyses increased their confidence in the results;

* concluded that the finding of an increased risk of suicidality in

pediatric patients applied to all the drugs studied (Prozac, Zoloft,

Remeron, Paxil, Effexor, Celexa Wellbutrin, Luvox and Serzone) in controlled

clinical trials;

* recommended that any warning related to an increased risk of

suicidality in pediatric patients should be applied to all antidepressant

drugs,

including those that have not been studied in controlled clinical trials in

pediatric patients, since the available data are not adequate to exclude

any single medication from an increased risk;

* reached a split decision (15-yes, 8-no) regarding recommending a

" black-box " warning related to an increased risk for suicidality in pediatric

patients for all antidepressant drugs;

* endorsed a patient information sheet ( " Medication Guide " ) for this

class of drugs to be provided to the patient or their caregiver with every

prescription;

* recommended that the products not be contraindicated in this

country because the Committees thought access to these therapies was important

for those who could benefit; and

* recommended that the results of controlled pediatric trials of

depression be included in the labeling for antidepressant drugs.

#

_RSS Feed for FDA News Releases_

(http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/PressReleases/rss.\

xml) _[what is RSS?]_

(http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/ucm144575.htm)

**************Dell Deals: Treat yourself to a sweet deal on popular

laptops!

(http://pr.atwola.com/promoclk/100126575x1223100673x1201716527/aol?redir=http:%2\

F%2Faltfarm.mediaplex.com%2Fad%2Fck%2F12309%2D81939%2D1629%2D7)